Skip to main content

10 Result(s)

within L. P. Koh Remove this filter Cell Biology Remove this filter Internal Medicine Remove this filter

and

  1. No Access

    Article

    Imatinib mesylate (STI-571) given concurrently with nonmyeloablative stem cell transplantation did not compromise engraftment and resulted in cytogenetic remission in a patient with chronic myeloid leukemia in blast crisis

    The main obstacles to successful hematopoietic stem cell transplantation for patients with chronic myeloid leukemia (CML) in blast crisis (BC) are increased post-transplant relapse and high treatment-related m...

    L P Koh, W Y K Hwang, C T H Chuah, Y C Linn, Y T Goh… in Bone Marrow Transplantation (2003)

  2. No Access

    Article

    A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation

    We initiated a randomized study of amifostine (the organic thiophosphate formerly known as WR-2721) given to patients during myeloablative conditioning therapy for allogeneic bone marrow transplantation. Amifo...

    W Y K Hwang, L-P Koh, H J Ng, P H C Tan, C T H Chuah… in Bone Marrow Transplantation (2004)

  3. No Access

    Article

    Haploidentical hematopoietic cell transplantation

    Haploidentical hematopoietic stem cell transplantation (HSCT) provides an opportunity for nearly all patients to benefit from HCT when a HLA genotypically matched sibling is not available. Initial results with...

    L-P Koh, N Chao in Bone Marrow Transplantation (2008)

  4. No Access

    Article

    Stem cell transplantation programme at Singapore General Hospital

    The adult transplant programme at Singapore General Hospital (SGH) was established in 1985 and more than 820 transplants have been performed to date. An average of about 60 adult transplants (autologous and al...

    M B C Koh, Y T Goh, P H C Tan, L P Koh, W Y K Hwang, Y Loh… in Bone Marrow Transplantation (2008)

  5. No Access

    Article

    Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib

    L-M Poon, L P Koh in Bone Marrow Transplantation (2012)

  6. No Access

    Article

    Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group

    Eighteen patients (men=14; women=4) with natural killer (NK)/T-cell lymphomas (CR1, N=9; CR2, N=7; PR, N=1; progressive disease, N=1) undergoing allogeneic haematopoietic SCT (HSCT) (myeloablative, N=14; reduced ...

    E Tse, T S Y Chan, L-P Koh, W-J Chng, W-S Kim, T Tang… in Bone Marrow Transplantation (2014)

  7. No Access

    Article

    Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working Group

    The clinical outcome of multiple myeloma is heterogeneous. Both the depth of response to induction and transplant as well as early relapse within a year are correlated with survival, but it is unclear which fa...

    S Y Ong, S de Mel, Y X Chen, M G Ooi, S Surendran, A Lin… in Bone Marrow Transplantation (2016)

  8. No Access

    Article

    An exploration of the applicability of the refined disease risk index and its integration with other independent risk factors for individualized prognostication

    The refined disease risk index (DRI) is a powerful prognostic model based solely on the disease type and stage for predicting survival outcomes of various hematological malignancies after allogeneic transplant...

    V V Maka, L-P Koh, C Diong, Y-T Goh, S Gopalakrishnan, A Ho… in Bone Marrow Transplantation (2017)

  9. No Access

    Article

    Safety and cost-effectiveness of outpatient autologous transplantation for multiple myeloma in Asia: single-center perspective from Singapore

    M B Abid, D Christopher, M A Abid, M L Poon, L K Tan… in Bone Marrow Transplantation (2017)

  10. No Access

    Article

    Role of upfront autologous transplant for peripheral T-cell lymphoma patients achieving a complete remission with first-line therapy: a systematic review and meta-analysis

    There is currently no consensus on the role of upfront autologous transplantation (ASCT) for patients with peripheral T-cell lymphomas (PTCL), especially in patients achieving first complete remission (CR1) fo...

    L. Girard, Y. J. Koh, L. P. Koh, Y. L. Chee, H. L. Chan… in Bone Marrow Transplantation (2024)